Opportunity Information: Apply for RFA AA 21 001
The grant opportunity "Improving Health Disparities in Alcohol Health Services (R01 Clinical Trial Optional)" is a National Institutes of Health (NIH) funding initiative from the National Institute on Alcohol Abuse and Alcoholism (NIAAA). It was announced as a discretionary grant opportunity under Funding Opportunity Number RFA-AA-21-001 (CFDA 93.273) and uses the R01 mechanism, meaning it is intended for mature, hypothesis-driven research projects that can support a substantial program of work. The "Clinical Trial Optional" label indicates that applicants may propose studies that include clinical trials, but a clinical trial is not required; projects can range from observational and intervention research through pragmatic or implementation-focused trials, as long as they fit the FOA goals.
The central purpose of the FOA is to strengthen evidence on how to reduce and ultimately eliminate health disparities in alcohol-related health services. NIAAA is explicitly looking for research that addresses unequal access, quality, uptake, and outcomes of alcohol prevention and treatment services across populations that experience disproportionate burden or barriers. While the FOA identifies five areas of emphasis, it is clear that proposals are expected to foreground the health disparities component rather than treating it as a secondary angle. In practice, that means applicants should define the disparity being targeted, identify the population(s) affected, explain the structural, social, economic, geographic, cultural, or system-level mechanisms driving inequity, and propose methods that can produce actionable findings for real-world alcohol health services.
The FOA highlights five focus areas that can serve as the main entry points for an application. First, "access to treatment" covers research aimed at improving the ability of individuals and communities to obtain alcohol-related services, which can include availability of providers, geographic reach (including rural and frontier settings), transportation and telehealth, referral pathways, wait times, insurance and eligibility barriers, language access, and justice-system or child-welfare interfaces that shape who gets care and when. Second, "making treatment more appealing" points toward work on acceptability, engagement, and retention, such as reducing stigma, tailoring services to cultural preferences and lived experience, improving patient-centered care, increasing trust, aligning services with community priorities, and designing interventions that people are willing to start and continue. Third, "costs" includes studies evaluating affordability and financial barriers, cost-effectiveness, reimbursement models, provider incentives, and broader economic analyses that can help decision-makers allocate resources in ways that reduce inequities. Fourth, "dissemination and implementation" emphasizes how evidence-based alcohol interventions are adopted, adapted, delivered, and sustained in real-world systems like primary care, specialty treatment programs, hospitals, community organizations, schools, and correctional settings, including the policies and organizational factors that influence equitable implementation. Fifth, "health disparities" is both a standalone focus and an expected cross-cutting theme, signaling that applications should directly test or evaluate strategies that narrow gaps between groups and address the conditions producing those gaps.
A key practical takeaway is that competitive applications are likely to connect at least one of the first four service-related domains to a disparities-focused research question, rather than studying services in general populations without a clear inequity target. For example, an access study might examine how expanding telehealth alcohol treatment affects uptake among underserved rural communities, or how integrating screening and brief intervention in safety-net clinics changes treatment initiation among minoritized groups. An acceptability study might test culturally responsive engagement strategies designed with community partners to improve retention. A cost study might evaluate whether certain payment models widen or narrow disparities in treatment availability. An implementation study might assess whether an evidence-based program is delivered with fidelity and equity across sites serving different populations, and what adaptations are necessary to prevent inequitable outcomes.
Eligibility for this FOA is broad and includes many types of U.S.-based organizations and governmental units. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities and Indian housing authorities; Native American tribal organizations other than federally recognized tribal governments; nonprofits with and without 501(c)(3) status (excluding higher education institutions in those nonprofit categories); for-profit organizations other than small businesses; small businesses; and other organizations as permitted under NIH rules. The FOA also explicitly calls out additional eligible applicant types that align with the disparities emphasis, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and applicants from a U.S. territory or possession.
At the same time, the FOA places clear limits on foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply. Non-domestic components of U.S. organizations are also not eligible to apply, and foreign components as defined by the NIH Grants Policy Statement are not allowed. In other words, the applicant organization must be domestic, and the work must not rely on foreign components under NIH definitions for this announcement.
From a funding perspective, the listed award ceiling is $500,000, which signals an upper limit for the budget request under this opportunity as presented in the source data. The original closing date in the provided record is March 15, 2021, and the opportunity was created on December 28, 2020, reflecting the timing of that specific announcement. The sponsor indicated an intent to renew this initiative, meaning NIAAA aimed to continue this line of funding through a renewed FOA, but the summary you provided is tied to the specific opportunity record and its stated dates and constraints.
Overall, this FOA is best understood as a call for rigorous alcohol health services research that produces practical, equity-centered solutions. NIAAA is signaling interest in studies that go beyond documenting disparities to testing strategies that improve service reach, appeal, affordability, implementation quality, and ultimately outcomes for populations that have been historically underserved or disproportionately harmed by alcohol-related conditions.Apply for RFA AA 21 001
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Improving Health Disparities in Alcohol Health Services (R01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273.
- This funding opportunity was created on 2020-12-28.
- Applicants must submit their applications by 2021-03-15. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the name of this grant opportunity?
The opportunity is titled "Improving Health Disparities in Alcohol Health Services (R01 Clinical Trial Optional)".
Which federal agency and institute are sponsoring this opportunity?
This is a National Institutes of Health (NIH) funding opportunity from the National Institute on Alcohol Abuse and Alcoholism (NIAAA).
What is the Funding Opportunity Number (FOA number) for this grant?
The Funding Opportunity Number is RFA-AA-21-001.
What is the CFDA number listed for this opportunity?
The opportunity references CFDA 93.273.
What grant mechanism does this opportunity use?
This FOA uses the R01 mechanism, which is intended for mature, hypothesis-driven research projects that can support a substantial program of work.
What does "Clinical Trial Optional" mean for this FOA?
"Clinical Trial Optional" means applicants may propose studies that include clinical trials, but a clinical trial is not required. Projects can include observational studies, intervention research, pragmatic trials, or implementation-focused trials, as long as they align with the FOA's goals.
What is the central purpose of this funding opportunity?
The central purpose is to strengthen evidence on how to reduce and ultimately eliminate health disparities in alcohol-related health services, including disparities in access, quality, uptake, and outcomes of alcohol prevention and treatment services.
What does NIAAA mean by "health disparities" in alcohol health services for this FOA?
Based on the FOA description, health disparities include unequal access, quality, uptake, and outcomes in alcohol prevention and treatment services across populations that face disproportionate burden or barriers. The FOA expects applicants to clearly define the disparity, identify affected population(s), and explain mechanisms driving inequity (for example, structural, social, economic, geographic, cultural, or system-level factors).
Is it enough to include disparities as a secondary element of a general alcohol services study?
No. The FOA emphasizes that proposals are expected to foreground the health disparities component rather than treating it as a secondary angle. Applicants should center the inequity being addressed and produce findings that are actionable for real-world alcohol health services.
What types of research approaches fit this FOA?
The FOA allows a range of approaches, including observational research, intervention research, and pragmatic or implementation-focused trials (if proposed). The key requirement is that the work fits the FOA goals of improving equity in alcohol health services.
What are the five focus areas highlighted in the FOA?
The FOA highlights five areas of emphasis:
- Access to treatment
- Making treatment more appealing (acceptability, engagement, retention)
- Costs (affordability, cost-effectiveness, reimbursement and incentive models)
- Dissemination and implementation (adoption, adaptation, delivery, sustainability in real-world settings)
- Health disparities (standalone focus and cross-cutting expectation)
What kinds of topics fall under "access to treatment" in this FOA?
"Access to treatment" can include research on provider availability, geographic reach (including rural and frontier settings), transportation and telehealth, referral pathways, wait times, insurance and eligibility barriers, language access, and interfaces with the justice system or child welfare that shape who gets care and when.
What does "making treatment more appealing" mean in practice?
This focus area points to research on acceptability, engagement, and retention, such as reducing stigma, tailoring services to cultural preferences and lived experience, improving patient-centered care, increasing trust, aligning services with community priorities, and designing services and interventions that people are willing to start and continue.
What types of studies are included under the "costs" focus area?
The "costs" area includes work on affordability and financial barriers, cost-effectiveness, reimbursement models, provider incentives, and broader economic analyses to help decision-makers allocate resources in ways that reduce inequities.
What does the FOA mean by "dissemination and implementation" for alcohol health services?
This area focuses on how evidence-based alcohol interventions are adopted, adapted, delivered, and sustained in real-world systems such as primary care, specialty treatment programs, hospitals, community organizations, schools, and correctional settings. It also includes policy and organizational factors that influence equitable implementation.
Does the FOA expect applicants to connect service-related domains to disparities questions?
Yes. A key takeaway from the FOA is that competitive applications are likely to connect one or more service-related domains (access, appeal/engagement, costs, implementation) to a disparities-focused research question, rather than studying services in general populations without a clear inequity target.
What are examples of the kinds of disparities-centered questions this FOA seems to encourage?
Examples described in the FOA summary include: examining how expanding telehealth alcohol treatment affects uptake among underserved rural communities; integrating screening and brief intervention in safety-net clinics and evaluating treatment initiation among minoritized groups; testing culturally responsive engagement strategies designed with community partners to improve retention; evaluating whether payment models widen or narrow disparities in treatment availability; and assessing whether evidence-based programs are delivered with fidelity and equity across sites serving different populations.
Who is eligible to apply for this opportunity?
Eligibility is broad and includes many types of U.S.-based organizations and governmental units. Eligible applicants include:
- State governments; county governments; city or township governments; special district governments
- Independent school districts
- Public and state-controlled institutions of higher education; private institutions of higher education
- Federally recognized Native American tribal governments
- Public housing authorities and Indian housing authorities
- Native American tribal organizations other than federally recognized tribal governments
- Nonprofits with and without 501(c)(3) status (excluding higher education institutions in those nonprofit categories)
- For-profit organizations other than small businesses; small businesses
- Other organizations as permitted under NIH rules
Are minority-serving institutions and community-based organizations explicitly included as eligible applicants?
Yes. The FOA explicitly calls out additional eligible applicant types aligned with the disparities emphasis, including Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, HBCUs, TCCUs, as well as faith-based or community-based organizations, eligible federal agencies, regional organizations, and applicants from a U.S. territory or possession.
Are foreign (non-U.S.) organizations eligible to apply?
No. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply under this announcement.
Can a U.S.-based applicant include a foreign component or non-domestic component in the project?
No. The FOA states that non-domestic components of U.S. organizations are not eligible to apply, and foreign components (as defined by the NIH Grants Policy Statement) are not allowed for this announcement.
What is the listed award ceiling for this opportunity?
The listed award ceiling in the provided record is $500,000, indicating an upper limit for the budget request as presented in the source data.
When was this opportunity created, and what was the original closing date?
The record indicates the opportunity was created on December 28, 2020, and the original closing date listed is March 15, 2021.
Does the sponsor plan to renew this initiative?
The sponsor indicated an intent to renew this initiative, meaning NIAAA aimed to continue this line of funding through a renewed FOA. The details provided here, however, are tied to the specific opportunity record and its stated dates and constraints.
What types of settings does the FOA consider "real-world systems" for dissemination and implementation research?
The FOA examples include primary care, specialty treatment programs, hospitals, community organizations, schools, and correctional settings as real-world systems where evidence-based alcohol interventions may be adopted, adapted, delivered, and sustained.
What does the FOA suggest reviewers may look for regarding mechanisms driving inequity?
From the FOA description, applicants are expected to explain the mechanisms driving inequity, which may include structural, social, economic, geographic, cultural, or system-level factors, and to propose methods that can produce actionable findings for alcohol health services.
What is the overall "best fit" description of this FOA?
This FOA is best understood as a call for rigorous alcohol health services research that produces practical, equity-centered solutions and goes beyond documenting disparities to testing strategies that improve service reach, appeal, affordability, implementation quality, and outcomes for populations that have been historically underserved or disproportionately harmed by alcohol-related conditions.
Browse more opportunities from the same category: Health
Next opportunity: Homeless Veterans’ Reintegration Program (HVRP), Incarcerated Veterans’ Transition Program (IVTP), and the Homeless Female Veterans’ and Veterans’ with Families Program (HFVVWF) (referred to collectively as HVRP)
Previous opportunity: NEA Arts Education Partnership (AEP), FY2020
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AA 21 001
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AA 21 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional) Apply for PAR 21 121 Funding Number: PAR 21 121 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| New Approaches to Identify Neurogenesis and Study its Dynamics in Brain Aging and AD/ADRD (R01 Clinical Trial Not Allowed) Apply for RFA AG 22 006 Funding Number: RFA AG 22 006 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Tuberculosis Research Advancement Centers (P30 Clinical Trials Not Allowed) Apply for RFA AI 21 001 Funding Number: RFA AI 21 001 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| Cellular Senescence Network: Consortium Organization and Data Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA RM 21 010 Funding Number: RFA RM 21 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cellular Senescence Network: Technology Development and Application (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA RM 21 009 Funding Number: RFA RM 21 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cellular Senescence Network: Tissue Mapping Centers (U54 Clinical Trial Not Allowed) Apply for RFA RM 21 008 Funding Number: RFA RM 21 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 21 033 Funding Number: RFA AG 21 033 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed) Apply for PAR 21 089 Funding Number: PAR 21 089 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) Apply for PAR 21 109 Funding Number: PAR 21 109 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) Apply for RFA TR 21 010 Funding Number: RFA TR 21 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00 Independent Clinical Trial Not Allowed) Apply for PAR 21 108 Funding Number: PAR 21 108 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 21 083 Funding Number: PAR 21 083 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) Apply for PAR 21 082 Funding Number: PAR 21 082 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R33 Clinical Trial Required) Apply for PAR 21 118 Funding Number: PAR 21 118 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Optional) Apply for RFA TR 21 008 Funding Number: RFA TR 21 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Infectious Etiology of Alzheimer's Disease (R01 Clinical Trial Optional) Apply for RFA AG 21 034 Funding Number: RFA AG 21 034 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required) Apply for PAR 21 119 Funding Number: PAR 21 119 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Basic Experimental Studies with Humans Required) Apply for PAR 21 096 Funding Number: PAR 21 096 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Biomedical Research Facilities (C06 Clinical Trial Not Allowed) Apply for PAR 21 139 Funding Number: PAR 21 139 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Clinical Trial Not Allowed) Apply for PAR 21 095 Funding Number: PAR 21 095 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AA 21 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.